$27.5M to Leidos
IGF::OT::IGF RESEARCH, DEVELOPMENT, PRODUCTION AND SUPPORT FOR CLINICAL TRIALS ? BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES (BNMABS)
- Company
- LDOSLeidos
- Recipient name in record
- LEIDOS BIOMEDICAL RESEARCH INC
- Awarded by
- Department of Health and Human Services · National Institutes of Health
- Value
- $27.5M
- Start date
- 19 Sep 2016
- End date
- 18 Sep 2021
- Award ID
- HHSN26100019
- Source
- View official record on USAspending.gov ↗
The match between the recipient name and the listed company is made by StockRoz and can contain errors.